Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies.
about
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosusAutoimmunity in 2015.Current treatment of antiphospholipid syndrome: lights and shadows.Aspirin and multiple sclerosisAntiphospholipid Antibodies in Lupus Nephritis.Antiphospholipid syndrome: an update.Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?SLE: the changing prognosis.What is known about pediatric antiphospholipid syndrome?Management of cardiovascular risk in systemic lupus erythematosus: a systematic review.Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies.Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study.Pediatric antiphospholipid syndrome.Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE.Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey.Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity.Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.A importância de reconhecer a síndrome antifosfolípide na medicina vascular.Obstetric antiphospholipid syndrome
P2860
Q28072610-29DF4848-4996-4C0B-A5B5-00B4CD2EE6FFQ30248983-8781FA78-92EB-457D-B1E4-E4E440023DE6Q33423959-E914C386-8E97-411E-BC81-E2D3523ABB4EQ35678040-3E787741-B316-46AB-9B32-B6150175FE4CQ36060060-F440D609-63D5-4E22-A2F2-A0CE83972600Q38410376-1AAB9D12-95AC-4B52-A06B-DE23BF9AB131Q38794847-10BBCDDA-E545-42D4-8033-FA7AC4010674Q38852499-BF1E78D2-BA23-4C0A-97E3-54A000C631BEQ38951210-4951EC47-97FC-48AC-B733-834323CEFE53Q39272988-0B0113A9-8C4C-48E9-9A57-A3CDA04DBFE7Q40115024-DFEBE815-B3CF-4E85-A98D-2E3B8C6F1409Q40725518-54B66288-BCF6-47BC-9D1D-3874C045B5DBQ41100232-11A17869-628A-41D5-8C26-D794F0827C72Q41128018-21393306-86ED-464B-BE17-EE10B6385DA5Q47551794-9C4FB8BB-92D8-4665-ACF3-AA8632032AABQ50640109-DD903BDF-36C0-43D4-95DA-6905028EB0C0Q51314663-BC9B01E5-3D3A-4310-9AB2-C8F285EBA9D9Q55208303-5483B917-A0FC-4144-81BE-A34C54BF5467Q55279180-93BFC643-6D1B-445F-A86F-FAA6FA06AE5BQ58551653-A3CC8CE0-DAA1-401E-95A6-8F11F1AA05F4
P2860
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Patient-level analysis of five ...... h antiphospholipid antibodies.
@en
type
label
Patient-level analysis of five ...... h antiphospholipid antibodies.
@en
prefLabel
Patient-level analysis of five ...... h antiphospholipid antibodies.
@en
P2093
P50
P921
P1433
P1476
Patient-level analysis of five ...... th antiphospholipid antibodies
@en
P2093
Alexis Mathian
Amelia Ruffatti
Denis Wahl
Hervé Devilliers
Juan Balasch
Laurent Arnaud
Maria Angeles Martinez-Zamora
Ricardo Forastiero
Zahir Amoura
P304
P356
10.1016/J.AUTREV.2014.10.019
P577
2014-10-22T00:00:00Z